AGFA HealthCare
14.5.2024 15:06:12 CEST | ACCESS Newswire | Press release
MORTSEL, BELGIUM / ACCESSWIRE / May 14, 2024 / AGFA HealthCare is pleased to announce that St. Vincent's Private Hospital in Dublin, Ireland, has chosen to implement AGFA HealthCare's Enterprise Imaging. This five-year agreement includes Enterprise Imaging for both Radiology and Breast Imaging, structured and precision reporting modules, Best in KLAS XERO® Universal Viewer, AGFA's Scheduling solution, Business Intelligence, Patients and Clinician portal, and a Managed Services contract.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.Near-real-time image access
St. Vincent's Private Hospital is the largest acute private hospital in Dublin and part of the only integrated multi-hospital campus in Ireland. The Enterprise Imaging Platform will deliver the advanced capabilities and robust availability that the hospital needs.
"St. Vincent's Private Hospital is a unique healthcare environment. As we are on the same grounds as St. Vincent's University Hospital, we can share resources, expertise and medical facilities with this leading academic teaching establishment. This enables us to deal with a high volume of patients, often who have complex medical requirements. Imaging is core to this care. AGFA HealthCare's Enterprise Imaging will give us the reliable, robust platform that we need, whilst delivering very fast access to studies. Furthermore, AGFA HealthCare is able to support this system with managed services and monitoring that will maximise our uptime, while minimising the burden on our own resources," says Tim Aseervatham, Healthcare/Diagnostic Informatics Manager for St. Vincent's Private Hospital.
"We are proud of the trust that St. Vincent's Private Hospital - a key healthcare player in Ireland - is placing in AGFA HealthCare. This further demonstrates the success of our long-standing commitment to delivering solutions that improve the delivery of healthcare to patients in both the private and public healthcare sector in Ireland and beyond. Enterprise Imaging enables the creation of a secure, modular and scalable ecosystem, which helps the hospital to reduce complexity, improve clinical collaboration, and enhance workflow efficiency. By empowering all users to access imaging studies in near-real-time, it will allow them to focus on tasks that add value to both their patients' care and experience," says Colin Foley, Regional Business Manager for AGFA HealthCare Ireland.
Seamless care and collaboration
The Radiology Department at St. Vincent's Private Hospital is one of the largest radiology services in the country, offering a full range of diagnostic and interventional services. It performs over 65,000 studies every year, including X-ray, CT, mammography, MRI, ultrasound, fluoroscopy and DEXA. The department is made up of 18 consultant radiologists working in conjunction with highly qualified radiographers and nurses and supported by experienced administrators.
Enterprise Imaging will integrate with the hospital's existing pillar and patient referral systems and will replace all paper-based workflows. The five-year agreement includes:
- Enterprise Imaging for Radiology and Breast Imaging: a one-of-a-kind, seamless and secure platform designed to build a connected, collaborative, and scalable community of care. Enterprise Imaging delivers "life in flow" to meet radiologists' daily challenges through a highly focused, efficient and customisable experience.
- Best in KLAS XERO® Universal Viewer: provides patient-centric image access across the enterprise, with pixel streaming in near-real time on almost any device with no downloads or data moves, and enhanced viewing with clinical depth, collaboration and sharing, all on a single web viewer.
- Business Intelligence: enables easy-to-access reports and tools for gathering, organising, analysing and managing clinical, quality, financial and administrative data.
- Scheduling: facilitates managing appointments and orders for even the most complex imaging procedures in one easy and quick web-based application.
- Structured and precision reporting, including ACR BI-RADS® ATLAS and ACR PI-RADS® ATLAS: fully integrated in the Enterprise Imaging Platform, it combines customisation with automation to support clear communication and enhanced decision-making.
- Workflow orchestration: intelligently and automatically assigns tasks to radiologists, based on the chosen criteria.
- Collaboration tools: support multidisciplinary teams with the multimedia patient images they need, wherever they are, including at the point of care.
- Actionable findings notification: closes the loop between radiologists and clinicians through rapid and effective communication of incidental and critical imaging findings.
- Native 3D tools and advanced visualisation, plus seamlessly embedded third-party clinical application.
- Portal for patients and physicians: makes it easy for patients and physicians outside of the hospital to access medical images and results.
- Managed services and monitoring: support optimal maintenance and uptime of this flexible and high-performance solution.
We are delighted to welcome St Vincent's Hospital to #TeamAGFA and are honoured to add such a prestigious hospital to our customer base.
About AGFA HealthCare
At AGFA HealthCare, we are transforming the delivery of care - supporting healthcare professionals across the globe with secure, effective, and sustainable imaging data management. As a company, we are dedicated to our customers, and we have harnessed a value framework of Mission, Vision and Customer Delivery Principles into our routine operations. Through these principles, we commit a consistent high-yield code of conduct to our associates - channelling our experience and aspirations to all of our stakeholders. Our Empowerer profile supports our focus on creating an exceptional experience through the power of technology and is an integral foundation to our company standards. AGFA HealthCare is a division of the Agfa-Gevaert Group. For more information on AGFA HealthCare, please visit www.agfahealthcare.com and follow us on LinkedIn.
AGFA and the Agfa rhombus are registered trademarks of Agfa-Gevaert N.V. Belgium or its affiliates. XERO® is a registered trademark of AGFA HealthCare N.V., Belgium. BI-RADS and PI-RADS are registered trademarks of the American College of Radiology. All rights reserved. All information contained herein is intended for guidance purposes only, and the characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. AGFA HealthCare diligently strives to provide as accurate information as possible but shall not be responsible for any typographical error.
Contact Information
Buse Kayar
buse.kayar@issuerdirect.com
SOURCE: AGFA HealthCare
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
